LEADER 00000cam a2200841Ma 4500 001 823040851 003 OCoLC 005 20240129213017.0 006 m o d 007 cr |n||||||||| 008 121231s2012 enka ob 001 0 eng d 010 2012931668 019 794113024|a865333538|a875290994|a880637925|a1065714197 |a1103266807|a1129357098|a1152973060|a1192350531 |a1235831322|a1240531155|a1243613287|a1262683295 020 0857096079|q(electronic bk.) 020 9780857096074|q(electronic bk.) 029 1 DEBBG|bBV042032812 029 1 DEBBG|bBV042314957 029 1 DEBSZ|b414182863 029 1 DEBSZ|b414264487 029 1 DEBSZ|b431578796 029 1 GBVCP|b800007271 029 1 CHNEW|b001010864 035 (OCoLC)823040851|z(OCoLC)794113024|z(OCoLC)865333538 |z(OCoLC)875290994|z(OCoLC)880637925|z(OCoLC)1065714197 |z(OCoLC)1103266807|z(OCoLC)1129357098|z(OCoLC)1152973060 |z(OCoLC)1192350531|z(OCoLC)1235831322|z(OCoLC)1240531155 |z(OCoLC)1243613287|z(OCoLC)1262683295 037 CL0500000435|bSafari Books Online 040 YDXCP|beng|epn|cYDXCP|dOCLCO|dCUY|dE7B|dIDEBK|dN$T|dOPELS |dUMI|dDEBBG|dDEBSZ|dOCLCQ|dOTZ|dEBLCP|dOCLCQ|dOCLCF|dU3W |dD6H|dCEF|dWYU|dUAB|dAUD|dVT2|dOCLCQ|dTUHNV|dOCLCO|dOCLCQ |dOCLCO|dOCLCL 049 INap 082 04 616.02774 082 04 616.02774 099 eBook O’Reilly for Public Libraries 245 00 Progenitor and stem cell technologies and therapies / |cedited by Anthony Atala.|h[O'Reilly electronic resource] 260 Cambridge, UK ;|aPhiladelphia, PA :|bWoodhead Publishing, |c2012. 300 1 online resource (xxiii, 536 pages) :|billustrations. 336 text|btxt|2rdacontent 337 computer|bc|2rdamedia 338 online resource|bcr|2rdacarrier 490 1 Woodhead Publishing in materials,|x2049-9485 504 Includes bibliographical references and index. 505 0 Part 1 Basic principles of stem cells: Basic principles for stem cell culture -- Basic principles of human embryonic stem cells -- Basic principles in generating induced pluirpotent stem cells -- Basic principles of amniotic and placental stem cells -- Basic principles of cord blood stem cells -- Basic principles of multipotent stem cells. Part 2 Enabling cell therapy: Intellectual property claims to stem cell technologies: research, clinical testing and product sales -- Regulatory considerations of stem and progenitor cell-based products: US Food and Drug Administration -- Cell therapy commercialisation -- Stem cell tourism. Part 3 Tissue- specific progenitor cells: Adipose tissue-derived stem cell biology and therapy -- Umbilical cord blood (UCB) progenitor stem cell biology and therapy -- Auditory progenitor stem cell biology and therapy -- Olfactory mucosa: neural stem and progenitor cells for nervous system repair and cell models of brain disease -- Oral cavity progenitor and stem cell biology and therapy -- Bone marrow mesenchymal progenitor and stem cell biology and therapy -- Progenitor and stem cell therapies for cartilage repair -- Cardiac stem and progenitor cell biology and therapy -- Renal progenitor and stem cell biology and therapy -- Lung progenitor and stem cell biology and therapy -- Genitourinary progenitor and stem cell biology and therapy. 520 Progenitor and stem cells have the ability to renew themselves and change into a variety of specialised types, making them ideal materials for therapy and regenerative medicine. Progenitor and stem cell technologies and therapies reviews the range of progenitor and stem cells available and their therapeutic application. Part one reviews basic principles for the culture of stem cells before discussing technologies for particular cell types. These include human embryonic, induced pluripotent, amniotic and placental, cord and multipotent stem cells. Part two discusses wider issues such as intellectual property, regulation and commercialisation of stem cell technologies and therapies. The final part of the book considers the therapeutic use of stem and progenitor cells. Chapters review the use of adipose tissue-derived stem cells, umbilical cord blood (UCB) stem cells, bone marrow, auditory and oral cavity stem cells. Other chapters cover the use of stem cells in therapies in various clinical areas, including lung, cartilage, urologic, nerve and cardiac repair. With its distinguished editor and international team of contributors, Progenitor and stem cell technologies and therapies is a standard reference for both those researching in cell and tissue biology and engineering as well as medical practitioners investigating the therapeutic use of this important technology. Reviews the range of progenitor and stem cells available and outlines their therapeutic applicationExamines the basic principles for the culture of stem cells before discussing technologies for particular cell types, including human embryonic, induced pluripotent, amniotic and placental, cord and multipotent stem cellsIncludes a discussion of wider issues such as intellectual property, regulation and commercialisation of stem cell technologies and therapies. 588 0 Print version record. 590 O'Reilly|bO'Reilly Online Learning: Academic/Public Library Edition 650 0 Stem cells|xTransplantation. 650 0 Stem cells|xTherapeutic use. 650 0 Cellular therapy. 650 2 Stem Cell Transplantation 650 2 Cell- and Tissue-Based Therapy 650 6 Cellules souches|xGreffe. 650 6 Cellules souches|xEmploi en thérapeutique. 650 6 Thérapie cellulaire. 650 7 Cellular therapy|2fast 650 7 Stem cells|xTransplantation|2fast 700 1 Atala, Anthony,|d1958-|1https://id.oclc.org/worldcat/ entity/E39PBJgd7t4Bqdc3p6mB6xXjmd 776 08 |iPrint version:|z9781845699840|z184569984X 830 0 Woodhead Publishing in materials. 856 40 |uhttps://ezproxy.naperville-lib.org/login?url=https:// learning.oreilly.com/library/view/~/9781845699840/?ar |zAvilable on O'Reilly for Public Libraries 938 ProQuest Ebook Central|bEBLB|nEBL1575575 938 ebrary|bEBRY|nebr10641523 938 EBSCOhost|bEBSC|n672022 938 ProQuest MyiLibrary Digital eBook Collection|bIDEB |ncis26903822 938 YBP Library Services|bYANK|n9961104 994 92|bJFN